Ischemic disease of the kidneys


Cite item

Full Text

References

  1. Alcazar J. M., Rodicio J. L. Ischemic nephropathy: clinical characteristics and treatment. Am. J. Kidney Dis. 2000- 36- 883-893.
  2. Babbola K., Evans C., Moore R. H. Incidence of end-stage renal disease in medically treated patients with severe bilateral athrosclerotic renovascular disease. Ibid. 1998; 31: 971-977.
  3. Jacobson H. R. Ischemic renal disease: an overlooked clinical entity? Kidney Int. 1988; 34: 729-743.
  4. Schwartz С. J., White T. A. Stenosis of renal artery: an unselected necropsy study. Br. Med. J. 1964; 2: 1415-1421. - 10
  5. Rimmer J. M., Gennari J. Atherosclerotic renovascular disease and progressive renal failure. Ann. Intern. Med. 1993; 118; 712-719.
  6. Appel R. G., Bleyer A. J., Reavis S., Hansen K. J. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995; 48; 171-176.
  7. О 'Neil E. A., Hansen K. J., Canzanello V. J. et al. Prevalence of ischemic nephropathy in patients with renal insufficiency.Am. Surg. 1992; 58: 52-57.
  8. Fatica R. A., Port F. K., Young E. W. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am. J. Kidney Dis. 2001; 37: 1184-1190.
  9. Khan I. H., Cattop G. R. D., Edward N. et al. Influence of coexisting disease on survival on renal replacement therapy. Lancet 1993; 341:415-418.
  10. Zuccala A., Zuccheli P. Ischemic nephropathy: diagnosis and treatment. J. Nephrol. 1998; 11: 318-324.
  11. Zuccala A., Zuccheli P. Ischemic nephropathy. In: Davison A. M., Cameron J. S., Grunfeld J.-P. et al., eds. Oxford textbook of clinical nephrology. Oxford; 1998. 1445-1456.
  12. Fliser D., Ritz E. Renal haemodynamics in the elderly. Nephrol. Dial. Transplant. 1996; 11 (stippl. 9): 2-8.
  13. Харманов В. Н. Ишемическая болезнь почек. Тер. арх. 2001; 73 (6): 64-66.
  14. Anderson W. P., Woods R. L. Intrarenal effects of angiotensin II in renal artery stenosis. Kidney Int. 1987; 31 (suppl. 20): S157-S167.
  15. Wollenweber J., Sheps S. G., Davis G. D. Clinical course of atherosclerotic renovascular disease. Am. J. Cardiol. 1968; 91: 60-71.
  16. Johansson M., Herlitz H., Jensen G. et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J. Hypertens. 1999; 17: 1743-1750.
  17. Meyrier A. Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? Nephrol. Dial. Transplant. 1996; 11 (suppl. 9): 45-52.
  18. Kasinath B. S., Lewis E. J. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch. Intern. Med. 1987; 147: 1384-1385.
  19. Casio F. G., Zager R. A., Sharma H. M. Atheroembolic renal disease causes hypocomplementemia. Lancet 1985; 2: 118- 121.
  20. Zuccala A., Zuccheli P. A renal disease frequently found at postmortem, but rarely diagnosed in vivo. Nephrol. Dial. Transplant. 1997; 12: 1762-1767.
  21. Olin J. W., Melia M., Young J. R. et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990; 88 (1): 46N-51N.
  22. Vetrovec G. W., Landwehr D. M., Edwards V. L. Incidence of renal artery stenosis in hypertension patients undergoing coronary angiography. J. Intervent. Cardiol. 1989; 2: 69-76.
  23. Alcasar J. M., Marin R., Gomez-Campdera F. et al. Clinical charasteristics of ischaemic renal disease. Nephrol. Dial. Transplant. 2001; 16 (suppl. I): 74-77.
  24. Orth S. R. Smoking - a renal risk factor. Nephron 2000; 86: 12-26.
  25. Борисов И. А., Перов Ю. Л. Старческая почка. В кн.: Тареева И. Е. (ред.) Нефрология. М.; 2001. 509-525.
  26. Гордеев А. В. Патология почек у больных сахарным диабетом 2 типа пожилого возраста: Автореф. дис... д-ра мед. наук. М.; 2002.
  27. Kalra P. A., Mamtora H., Holmes A. M., Waldek S. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Quart. J. Med. 1990; 282: 1013-1018.
  28. Keane W. F., Anderson S., Aurell M. et al. Angiotensin-converting enzyme inhibitors and progressive renal insufficiency. Ann. Intern. Med. 1989; 111: 503-516.
  29. Toto R. D. Renal insufficiency due to angiotensin-convertring enzyme inhibitors. Miner. Electrolyte Metab. 1994; 20: 193- 200.
  30. Caps M. Т., Perissinoto C., Zierler R. E. et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-2872.
  31. van de Ven P. J., Beutler J. J., Kaatee R. et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998; 53: 986-993.
  32. Modi K. S., Rao V. K. Atheroembolic renal disease. J. Am. Soc. Nephrol. 2001; 12: 1781-1787.
  33. Krumme В., Blum U., Schwertfeger E. et al. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int. 1996: 50: 1288-1292.
  34. Riehl J., Schmitt H., Bongartz D. et al. Renal artery stenosis: evaluation with color duplex ultrasonography. Nephrol. Dial. Transplant. 1997; 12: 1608-1614.
  35. Maker E. R., Othman S., Frankel A. H. et al. Captopril enhanced 99mTc-DTPA scintigraphy in the detection of renal artery stenosis. Ibid. 1998; 13: 608-611.
  36. Davidson R. A., Barri Y. M., Wilcox С. S. The simplified captopril test: an effective tool to diagnose renovascular hypertension. Am. J. Kidney Dis. 1994; 24: 660-664.
  37. Krumme В., Mann J. F. E. Atherosclerotic renal artery stenosis in 2001 - are we less confused than before? Nephrol. Dial. Transplant. 2001; 16: 2124-2127.
  38. Olbricht С. J., Kunter U., Prokop M. et al. The diagnostic accuracy of spiral computer tomographic angiography for renal artery stenosis in patients with renal insufficiency. J. Am. Soc. Nephrol. 1995; 6: 646.
  39. Olbricht С. I., Galanski M., Ghavan A., Prokop M. Spiral CT angiography - can we forget about arteriography to diagnose renal artery stenosis? Nephrol. Dial. Transplant. 1996; 11: 1227-1231.
  40. Mounier-Vehier C., Lions C., Devos P. et al. Cortical thickness: an early morphological marker of atherosclerotic renal disease. Kidney Int. 2002; 61: 591-598.
  41. Chaikoff E. L., Smith R. В., Salam A. A. et al. Ischemic nephropathy and concomitant aoric disease: a ten-year experience.J. Vase. Surg. 1994; 19: 135-148.
  42. Paulsen D., Klow N. E., Rogstad B. et al. Preservation of renal function by percutaneous transluminal angioplasty in ischemic renal disease. Nephrol. Dial. Transplant. 1999; 14: 1454- 1461.
  43. van de Veen P. J. G., Kaatee R., Beutler J. J. et al. Arterial stenting and baloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet 1999; 353: 282- 286.
  44. Middleton J. P. Ischemic disease of the kidney: how and why to consider revascularization. J. Nephrol. 1998; 11: 123-136.
  45. Ploin P.-F., Rossignol P., Bobrie G. Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent or to operate? J. Am. Soc. Nephrol. 2001; 12: 2190-2196.
  46. Massy Z. A., Guijarro С. Statins: effects beyond cholesterol lowering. Nephrol. Dial. Transplant. 2001; 16: 1738-1741.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies